Increased prevalence of diverse N-methyl-D-aspartate glutamate receptor antibodies in patients with an initial diagnosis of schizophrenia: Specific relevance of IgG NR1a antibodies for distinction from N-methyl-D-aspartate glutamate receptor encephalitis

Johann Steiner^*, Martin Walter, Wenzel Glanz, Zoltán Sarnyai, Hans Gert Bernstein, Stefan Vielhaber, Andrea Kästner, Martin Skalej, Wolfgang Jordan, Kolja Schiltz, Christine Klingbeil, Klaus Peter Wandinger, Bernhard Bogerts, Winfried Stoecker

^*Korrespondierende/r Autor/-in für diese Arbeit

Institut für Klinische Chemie

328 Zitate (Scopus)

Fingerprint

Untersuchen Sie die Forschungsthemen von „Increased prevalence of diverse N-methyl-D-aspartate glutamate receptor antibodies in patients with an initial diagnosis of schizophrenia: Specific relevance of IgG NR1a antibodies for distinction from N-methyl-D-aspartate glutamate receptor encephalitis“. Zusammen bilden sie einen einzigartigen Fingerprint.

sortieren

Increased prevalence of diverse N-methyl-D-aspartate glutamate receptor antibodies in patients with an initial diagnosis of schizophrenia: Specific relevance of IgG NR1a antibodies for distinction from N-methyl-D-aspartate glutamate receptor encephalitis

Fingerprint

Pharmacology, Toxicology and Pharmaceutical Science

Neuroscience